• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glycomimetics Inc (NQ: GLYC )

0.3826 -0.0243 (-5.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,974,653
Open 0.4095
Bid (Size) 0.3518 (2)
Ask (Size) 0.3610 (586)
Prev. Close 0.4069
Today's Range 0.3750 - 0.4207
52wk Range 0.1406 - 3.530
Shares Outstanding 64,483,958
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC
October 31, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 30, 2024
Via Benzinga

Performance

YTD
-85.93%
-85.93%
1 Month
+139.42%
+139.42%
3 Month
+107.82%
+107.82%
6 Month
+21.27%
+21.27%
1 Year
-71.23%
-71.23%

More News

Read More
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
October 30, 2024
Via Benzinga
Why GlycoMimetics Stock is Trading Higher Monday
June 25, 2024
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders
October 29, 2024
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE - ARC)
October 29, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
October 29, 2024
Via Benzinga
GlycoMimetics Shares Are Soaring Tuesday: Here's Why
October 29, 2024
Via Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
October 29, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 29, 2024
Via Benzinga
Shareholder Alert: Ademi LLP Investigates Whether GlycoMimetics, Inc. is Obtaining a Fair Price for Its Public Shareholders
October 29, 2024
From Ademi LLP
Via Business Wire
US Stocks Mixed; McDonald's Posts Upbeat Earnings
October 29, 2024
Via Benzinga
GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders
October 29, 2024
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 29, 2024
Via Benzinga
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
October 29, 2024
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
October 29, 2024
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics Announces Strategic Review and Corporate Restructuring Plan
July 25, 2024
From GlycoMimetics, Inc.
Via Business Wire
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 26, 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Via InvestorPlace
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
June 21, 2024
Via Benzinga
GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
June 04, 2024
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024
May 29, 2024
From GlycoMimetics, Inc.
Via Business Wire
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
May 09, 2024
Via InvestorPlace
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
May 06, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap